Comparison of polypharmacy in clinic-based practices and hospital-based practices among patients with complex multimorbidity* (N=492)
| Outcome | Unadjusted | P value | Adjusted† | P value |
| Relative risk (95% CI) | Relative risk (95% CI) | |||
| Polypharmacy‡ | 0.55 (0.36 to 0.83) | 0.005 | 0.53 (0.35 to 0.82) | 0.004 |
| Number of regular medications | ||||
| Total | 0.85 (0.74 to 0.97) | 0.020 | 0.87 (0.78 to 0.97) | 0.014 |
| Prescription medications | 0.85 (0.73 to 0.98) | 0.029 | 0.86 (0.77 to 0.97) | 0.014 |
| Over-the-counter medications | 0.87 (0.60 to 1.27) | 0.475 | 0.90 (0.63 to 1.32) | 0.608 |
*Reference group: hospitals; generalised linear mixed model; random effect on facility.
†Adjusted for age, sex, years of education, annual household income, number of chronic conditions, eye and adnexa, digestive, and respiratory diseases, hospitalisation in past 6 months, and municipality population size.
‡Use of ≥5 concurrent medications.